Trials / Completed
CompletedNCT06298643
Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 177 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to describe the treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs of lower-risk myelodysplastic syndromes patients in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Red blood cell transfusion | ≥2 units of red blood cell transfusion |
| PROCEDURE | Red blood cell transfusion | 0 units or \<2 units of red blood cell transfusion |
Timeline
- Start date
- 2023-12-22
- Primary completion
- 2025-07-09
- Completion
- 2025-07-09
- First posted
- 2024-03-07
- Last updated
- 2025-12-04
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06298643. Inclusion in this directory is not an endorsement.